ArticleNPJ cardiovascular health2025
Characterizing lipoprotein profiles in coronary atherosclerosis development through quantitative lipidomics and proteomics approaches.
Article in NPJ cardiovascular health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of glucagon-like peptide-1 receptor agonists in type 2 diabetes-associated atherosclerosis: from vascular mechanism to omics-based biomarkers and imaging.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lipoproteins, synthesized in the liver and secreted into the bloodstream, play a central role in lipid transport. Although their quality affects cardiovascular outcomes, conventional markers do not fully explain the disease risk. We characterized the lipoprotein composition during coronary atherosclerosis progression in myocardial infarction-prone rabbits, which consistently develop severe aortic lesions but show variable coronary stenosis at 20 months. This variation allowed for the exploration of coronary-specific factors that are often masked by other models. Using quantitative lipidomics and proteomics, we profiled 237 lipids and four apolipoproteins in lipoproteins every four months. Coronary severity was positively correlated with long-chain saturated ceramide levels in very-low- and low-density lipoprotein particles, specifically at eight months, reflecting an early disease stage. This correlation was independent of apolipoproteins and classical risk factors, such as cholesterol and triacylglycerol. Network analysis revealed that lipid class-specific clusters were associated with disease severity. This unbiased multi-omics approach provides novel insights into the contribution of lipoprotein composition to coronary atherosclerosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.